DIAMMONIUM 2-((4-(ETHYL(4-SULFONATOBENZYL)AMINO)PHENYL)((4-(ETHYL(4-SULFONATOBENZYL)IMINIO)CYCLOHEXA-2,5-DIEN-1-YLIDENE)METHYL)BENZENESULFONATE
UNII 5130S0U11X
Substance Identification & Data
This profile provides standardized clinical and technical data for Diammonium 2-((4-(ethyl(4-sulfonatobenzyl)amino)phenyl)((4-(ethyl(4-sulfonatobenzyl)iminio)cyclohexa-2,5-dien-1-ylidene)methyl)benzenesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5130S0U11X.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 6371-85-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H34N2O9S3.2H4N TVCBMJCHKADLEE-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Diammonium 2-((4-(ethyl(4-sulfonatobenzyl)amino)phenyl)((4-(ethyl(4-sulfonatobenzyl)iminio)cyclohexa-2,5-dien-1-ylidene)methyl)benzenesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.